RWC-27590-45028
3 vaccinations
5 coded responses
37 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 371 / TN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-07
Health check-in — day 7, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-11
- 2021-02-17
- 2021-02-24
- 2021-03-05
- 2021-03-12
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Fibroadenoma of breast — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with fibroadenoma in breastMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-28
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-02
-
2021-10-29
Dose 3 — Moderna
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: no appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-05
-
2021-11-12
Survey response — day 14, dose 3MedDRA: Dry throat, Ear pruritus, Migraine, Throat irritation, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: itchy/dry throat, itchy ears, migraine, vomitingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
-
2021-12-05
Survey response — day 35, dose 3MedDRA: Abdominal pain, Appendicitis, Hospitalisation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: severe abdominal pain. hospitalized for preappendicitis · Healthcare visit (other): . hospitalized for preappendicitisMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-12-06
-
2021-12-06
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-10
-
2022-01-29
Survey response — 3 months, dose 3MedDRA: Laboratory test abnormal — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Positive for C DiffMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-01
- 2022-04-29
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
Call center
4 call center cases
2 successful · 1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with fibroadenoma in breast
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): no appetite
Release 10 — day 14, dose 3
Symptoms: itchy/dry throat, itchy ears, migraine, vomiting
Release 10 — day 35, dose 3
Symptoms: severe abdominal pain. hospitalized for preappendicitis
Healthcare visit (other): . hospitalized for preappendicitis
Release 11 — 3 months, dose 3
Symptoms: Positive for C Diff
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Appendicitis | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Appendicitis | · | · | ✓ |
| SD | Dry throat | · | · | ✓ |
| SD | Ear pruritus | · | · | ✓ |
| SD | Fibroadenoma of breast | ✓ | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release